Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Guermazi, A; Brice, P; de Kerviler, E; Ferme, C; Hennequin, C; Meignin, V; Frija, J
   Extranodal Hodgkin disease: Spectrum of disease
   RADIOGRAPHICS
   
   A. Guermazi et al., "Extranodal Hodgkin disease: Spectrum of disease", RADIOGRAPHI, 21(1), 2001, pp. 161-179
2. Brice, P; Colin, P; Berger, F; de Kerviler, E; Divine, M; Bouaffia, F; Kerneis, Y; Blanc, M; Lepage, E; Ferme, C
   Advanced Hodgkin disease with large mediastinal involvement can be treatedwith eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy - A study of 82 patients from the groupes d'Etudes des Lymphomes de ''adulte H89 Trial
   CANCER
   
   P. Brice et al., "Advanced Hodgkin disease with large mediastinal involvement can be treatedwith eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy - A study of 82 patients from the groupes d'Etudes des Lymphomes de ''adulte H89 Trial", CANCER, 92(3), 2001, pp. 453-459
3. Ferme, C; Cosset, JM; Fervers, B; Sebban, C; Cutuli, B; Henry-Amar, M; Stines, J; Giammarile, F; Bey, P; Carella, AM; Philip, T
   Hodgkins disease
   BRITISH JOURNAL OF CANCER
   
   C. Ferme et al., "Hodgkins disease", BR J CANC, 84, 2001, pp. 55-60
4. Camilleri-Broet, S; Audouin, J; Ferme, C; Briere, J; Pulford, K; Gaulard, P; Divine, M; Macintyre, E; Delsol, G; Berger, F
   ALK is not expressed in Hodgkin disease
   BLOOD
   
   S. Camilleri-Broet et al., "ALK is not expressed in Hodgkin disease", BLOOD, 97(6), 2001, pp. 1901-1902
5. Ferme, C; Sebban, C; Hennequin, C; Divine, M; Lederlin, P; Gabarre, J; Ferrant, A; Caillot, D; Bordessoule, D; Brice, P; Moullet, I; Berger, F; Lepage, E
   Comparison of chemotherapy to radiotherapy as consolidation of complete orgood partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the Groupe d'etudes des Lymphomes de l'Adulte H89 trial
   BLOOD
   
   C. Ferme et al., "Comparison of chemotherapy to radiotherapy as consolidation of complete orgood partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the Groupe d'etudes des Lymphomes de l'Adulte H89 trial", BLOOD, 95(7), 2000, pp. 2246-2252
6. Brice, P; Divine, M; Simon, D; Coiffier, B; Leblond, V; Simon, M; Voilat, L; Devidas, A; Morschhauser, F; Rohrlich, P; Andre, M; Lepage, E; Ferme, C
   Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD)
   ANNALS OF ONCOLOGY
   
   P. Brice et al., "Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD)", ANN ONCOL, 10(12), 1999, pp. 1485-1488
7. Ferme, C; Cosset, JM; Fervers, B; Sebban, C; Cutuli, B; Henry-Amar, M; Stines, J; Giammarile, F; Bey, P; Carella, AM; Philip, T
   Standards, options and recommendations for the management of patients withHodgkin's disease
   PRESSE MEDICALE
   
   C. Ferme et al., "Standards, options and recommendations for the management of patients withHodgkin's disease", PRESSE MED, 28(40), 1999, pp. 2233-2242
8. Fitoussi, O; Simon, D; Brice, P; Makke, J; Scrobohaci, ML; Triki, TB; Hennequin, C; Ferme, C; Gisselbrecht, C
   Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma
   BONE MARROW TRANSPLANTATION
   
   O. Fitoussi et al., "Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma", BONE MAR TR, 24(7), 1999, pp. 747-755
9. Flechtner, H; Ruffer, JU; Henry-Amar, M; Mellink, WAM; Sieber, M; Ferme, C; Eghbali, H; Josting, A; Diehl, V
   Quality of life assessment in Hodgkin's disease: A new comprehensive approach - First experiences from the EORTC/GELA and GHSG trials
   ANNALS OF ONCOLOGY
   
   H. Flechtner et al., "Quality of life assessment in Hodgkin's disease: A new comprehensive approach - First experiences from the EORTC/GELA and GHSG trials", ANN ONCOL, 9, 1998, pp. 147-154
10. MOREAU P; FLEURY J; BRICE P; COLOMBAT P; BOUABDALLAH R; LIOURE B; VOILLAT L; CASASNOVAS O; FRANCOIS S; SADOUN A; LAMY T; LOTZ JP; MUNCK JN; DIVINE M; FERME C; PENY AM; FRUCHART C; ORIOL P; OJEDA M; REMAN O; MILPIED N; GISSELBRECHT C; LEGROS M; HAROUSSEAU JL
    EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN ADVANCED HODGKINS-DISEASE - RETROSPECTIVE ANALYSIS OF 158 CASES FROM THE FRENCH REGISTRY
    Bone marrow transplantation
    
    P. Moreau et al., "EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN ADVANCED HODGKINS-DISEASE - RETROSPECTIVE ANALYSIS OF 158 CASES FROM THE FRENCH REGISTRY", Bone marrow transplantation, 21(8), 1998, pp. 787-793
11. BRICE P; DIVINE M; COIFFIER B; LEBLOND V; SIMON M; DEVIDAS A; SIMON D; ROHRLICH P; FERME C
    DOUBLE AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN REFRACTORY AND EARLY DISSEMINATED RELAPSE FROM HODGKINS-DISEASE (HD) - A PILOT-STUDY FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE/
    Bone marrow transplantation
    
    P. Brice et al., "DOUBLE AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN REFRACTORY AND EARLY DISSEMINATED RELAPSE FROM HODGKINS-DISEASE (HD) - A PILOT-STUDY FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE/", Bone marrow transplantation, 21, 1998, pp. 573-573
12. ANDRE M; HENRYAMAR M; BLAISE D; COLOMBAT P; FLEURY J; MILPIED N; CAHN JY; PICO JL; BASTION Y; KUENTZ M; NEDELLEC G; ATTAL M; FERME C; GISSELBRECHT C
    TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE
    Blood
    
    M. Andre et al., "TREATMENT-RELATED DEATHS AND 2ND CANCER RISK AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE", Blood, 92(6), 1998, pp. 1933-1940
13. ANDRE M; BRICE P; CAZALS D; HENNEQUIN C; FERME C; KERNEIS Y; ROUSSELOT P; ZINI JM; LEPAGE E; GISSELBRECHT C
    RESULTS OF 3 COURSES OF ADRIAMYCIN, BLEOMYCIN, VINDESINE, AND DACARBAZINE WITH SUBTOTAL NODAL IRRADIATION IN 189 PATIENTS WITH NODAL HODGKINS-DISEASE (STAGE-I, STAGE-II AND STAGE-IIIA)
    HEMATOLOGY AND CELL THERAPY
    
    M. Andre et al., "RESULTS OF 3 COURSES OF ADRIAMYCIN, BLEOMYCIN, VINDESINE, AND DACARBAZINE WITH SUBTOTAL NODAL IRRADIATION IN 189 PATIENTS WITH NODAL HODGKINS-DISEASE (STAGE-I, STAGE-II AND STAGE-IIIA)", HEM CELL TH, 39(2), 1997, pp. 59-65
14. GILLETTE JF; FERME C; MOISY N; MIGNOT L; SCHACH R; VIGNAUX JR; BESNER JG; CAILLE G; BELPOMME D
    DOUBLE-BLIND CROSSOVER CLINICAL AND PHARMACOKINETIC COMPARISON OF ORAL MORPHINE SYRUP AND SUSTAINED-RELEASE MORPHINE-SULFATE CAPSULES IN PATIENTS WITH CANCER-RELATED PAIN
    Clinical drug investigation
    
    J.F. Gillette et al., "DOUBLE-BLIND CROSSOVER CLINICAL AND PHARMACOKINETIC COMPARISON OF ORAL MORPHINE SYRUP AND SUSTAINED-RELEASE MORPHINE-SULFATE CAPSULES IN PATIENTS WITH CANCER-RELATED PAIN", Clinical drug investigation, 14, 1997, pp. 22-27
15. FERME C
    HODGKINS-DISEASE - CURRENT ASPECTS
    La Presse medicale
    
    C. Ferme, "HODGKINS-DISEASE - CURRENT ASPECTS", La Presse medicale, 26(23), 1997, pp. 1113-1122
16. FERME C; BASTION Y; BRICE P; LEDERLIN P; DIVINE M; GABARRE J; ASSOULINE D; FERRANT A; BERGER F; LEPAGE E
    PROGNOSIS OF PATIENTS WITH ADVANCED HODGKINS-DISEASE - EVALUATION OF 4 PROGNOSTIC MODELS USING 344 PATIENTS INCLUDED IN THE GROUP-DETUDES-DES-LYMPHOMES-DE-LADULTE STUDY
    Cancer
    
    C. Ferme et al., "PROGNOSIS OF PATIENTS WITH ADVANCED HODGKINS-DISEASE - EVALUATION OF 4 PROGNOSTIC MODELS USING 344 PATIENTS INCLUDED IN THE GROUP-DETUDES-DES-LYMPHOMES-DE-LADULTE STUDY", Cancer, 80(6), 1997, pp. 1124-1133
17. GUERMAZI A; FERME C; DEKERVILER E; FRIJA J; BRICE P
    DOES LYMPHANGIOGRAPHY STILL HAVE A PLACE IN THE STAGING OF HODGKIN DISEASE
    Radiology
    
    A. Guermazi et al., "DOES LYMPHANGIOGRAPHY STILL HAVE A PLACE IN THE STAGING OF HODGKIN DISEASE", Radiology, 199(1), 1996, pp. 283-283
18. BRICE P; BASTION Y; DIVINE M; NEDELLEC G; FERRANT A; GABARRE J; REMAN O; LEPAGE E; FERME C
    ANALYSIS OF PROGNOSTIC FACTORS AFTER THE FIRST RELAPSE OF HODGKINS-DISEASE IN 187 PATIENTS
    Cancer
    
    P. Brice et al., "ANALYSIS OF PROGNOSTIC FACTORS AFTER THE FIRST RELAPSE OF HODGKINS-DISEASE IN 187 PATIENTS", Cancer, 78(6), 1996, pp. 1293-1299
19. ANDRE M; HENRYAMAR M; PICO JL; BASTION Y; BLAISE D; KUENTZ M; COLOMBAT P; CAHN JY; ATTAL M; FLEURY J; MILPIED N; BIRON P; NEDELLEC G; JOUET JP; TILLY R; FERME C; GISSELBRECHT C
    AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IMPROVES SURVIVAL OF REFRACTORY HODGKINS-DISEASE (HD) PATIENTS - A RETROSPECTIVE MATCH-CONTROLLED STUDY
    Blood
    
    M. Andre et al., "AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IMPROVES SURVIVAL OF REFRACTORY HODGKINS-DISEASE (HD) PATIENTS - A RETROSPECTIVE MATCH-CONTROLLED STUDY", Blood, 88(10), 1996, pp. 479-479
20. MOREAU P; FLEURY J; BOUABDALLAH R; COLOMBAT P; BRICE P; LIOURE B; VOILLAT L; SADOUN A; FRANCOIS S; LAMY T; CASASNOVAS O; LINASSIER C; LEGROS M; MILPIED N; BASTION Y; BIRON P; ANDRE M; DIVINE M; FERME C; JOUET JP; HAROUSSEAU JL
    EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN HIGH-RISK HODGKINS-DISEASE (HD) - REPORT OF 158 CASES FROM THE FRENCH REGISTRY (SFGM)
    Blood
    
    P. Moreau et al., "EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN HIGH-RISK HODGKINS-DISEASE (HD) - REPORT OF 158 CASES FROM THE FRENCH REGISTRY (SFGM)", Blood, 88(10), 1996, pp. 1931-1931
21. GISSELBRECHT C; FERME C
    PROGNOSTIC FACTORS IN ADVANCED HODGKINS-DISEASE - PROBLEMS AND PITFALLS - TOWARDS AN INTERNATIONAL PROGNOSTIC INDEX
    Leukemia & lymphoma
    
    C. Gisselbrecht e C. Ferme, "PROGNOSTIC FACTORS IN ADVANCED HODGKINS-DISEASE - PROBLEMS AND PITFALLS - TOWARDS AN INTERNATIONAL PROGNOSTIC INDEX", Leukemia & lymphoma, 15, 1995, pp. 23-24
22. FERME C; BASTION Y; LEPAGE E; BERGER F; BRICE P; MOREL P; GABARRE J; NEDELLEC G; REMAN O; CHERON N; OBERLIN O; COIFFIER B
    THE MINE REGIMEN AS INTENSIVE SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY HODGKINS-DISEASE
    Annals of oncology
    
    C. Ferme et al., "THE MINE REGIMEN AS INTENSIVE SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY HODGKINS-DISEASE", Annals of oncology, 6(6), 1995, pp. 543-549
23. ANDRE M; HENRYAMAR M; BLAISE D; COLOMBAT P; FLEURY J; MILPIED N; GAHN JY; PICO JL; BASTION Y; KUENTZ M; BIRON P; FERME C; GISSELBRECHT C
    INCIDENCE OF 2ND CANCERS (SC) AND CAUSES OF DEATH AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR HODGKINS-DISEASE (HD)
    Blood
    
    M. Andre et al., "INCIDENCE OF 2ND CANCERS (SC) AND CAUSES OF DEATH AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR HODGKINS-DISEASE (HD)", Blood, 86(10), 1995, pp. 1826-1826
24. ANDRIVET P; BACQUER A; NGOC CV; FERME C; LETINIER JY; GAUTIER H; GALLET CB; BRUNBUISSON C
    LACK OF CLINICAL BENEFIT FROM SUBCUTANEOUS TUNNEL INSERTION OF CENTRAL VENOUS CATHETERS IN IMMUNOCOMPROMISED PATIENTS
    Clinical infectious diseases
    
    P. Andrivet et al., "LACK OF CLINICAL BENEFIT FROM SUBCUTANEOUS TUNNEL INSERTION OF CENTRAL VENOUS CATHETERS IN IMMUNOCOMPROMISED PATIENTS", Clinical infectious diseases, 18(2), 1994, pp. 199-206
25. TREDANIEL J; PEILLON I; FERME C; BRICE P; GISSELBRECHT C; HIRSCH A
    ENDOBRONCHIAL PRESENTATION OF HODGKINS-DISEASE - A REPORT OF 9 CASES AND REVIEW OF THE LITERATURE
    The European respiratory journal
    
    J. Tredaniel et al., "ENDOBRONCHIAL PRESENTATION OF HODGKINS-DISEASE - A REPORT OF 9 CASES AND REVIEW OF THE LITERATURE", The European respiratory journal, 7(10), 1994, pp. 1852-1855
26. FERME C; HENRYAMAR M
    HODGKINS-DISEASE MANAGEMENT AND FOLLOW-UP REVISITED
    Nouvelle revue francaise d'hematologie
    
    C. Ferme e M. Henryamar, "HODGKINS-DISEASE MANAGEMENT AND FOLLOW-UP REVISITED", Nouvelle revue francaise d'hematologie, 36(3), 1994, pp. 209-212
27. FERME C; BRICE P; GABARRE J; DIVINE M; DETOURMIGNIES L; JAUBERT J; CAILLOT D; BASTION Y; ASSOULINE D; NEDELLEC G; ISNARD F; TABAH I
    MINE CHEMOTHERAPY PLUS RHGM-CSF AS SALVAGE AND PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZING REGIMEN FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE (HD)
    Blood
    
    C. Ferme et al., "MINE CHEMOTHERAPY PLUS RHGM-CSF AS SALVAGE AND PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZING REGIMEN FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE (HD)", Blood, 84(10), 1994, pp. 10000162-10000162
28. FERME C; LEPAGE E; BRICE P; DAGAY MF; FERMAND JP; CASTAIGNE S; FRIJA J; MIOT C; MARTY M; GISSELBRECHT C
    COMBINED CHEMOTHERAPY-RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE - RESULTS OF A PROSPECTIVE CLINICAL-TRIAL WITH 70 STAGE IIIB-IV PATIENTS
    International journal of radiation oncology, biology, physics
    
    C. Ferme et al., "COMBINED CHEMOTHERAPY-RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE - RESULTS OF A PROSPECTIVE CLINICAL-TRIAL WITH 70 STAGE IIIB-IV PATIENTS", International journal of radiation oncology, biology, physics, 26(3), 1993, pp. 397-405
29. BRICE P; RAIN JD; FRIJA J; MIAUX Y; MAROLLEAU JP; TREDANIEL J; FERME C; HENNEQUIN C; GISSELBRECHT C
    RESIDUAL MEDIASTINAL MASS IN MALIGNANT-LYMPHOMA - VALUE OF MAGNETIC-RESONANCE-IMAGING AND GALLIUM SCAN
    Nouvelle revue francaise d'hematologie
    
    P. Brice et al., "RESIDUAL MEDIASTINAL MASS IN MALIGNANT-LYMPHOMA - VALUE OF MAGNETIC-RESONANCE-IMAGING AND GALLIUM SCAN", Nouvelle revue francaise d'hematologie, 35(4), 1993, pp. 457-461